Abaloparatide may help prevent fractures in postmenopausal women with osteoporosis
The investigational drug abaloparatide-SC (subcutaneous) may help increase bone mineral density in postmenopausal women and reduce their risk of fracture, new industry-sponsored research suggests. The results of the subgroup ...
Apr 3, 2016
0
18